
Elevance Health, Inc. (NYSE:ELV) shares fell Tuesday despite beating estimates, as Medicare cost pressures, Obamacare plan dynamics, and Medicaid attrition weighed on sentiment.
The company reported third-quarter adjusted earnings per share of $6.03, beating the analyst consensus estimate of $4.93.